Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Maikel Peppelenbosch"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/d6639c50580e4d73a17fd4702c0532b7
Autor:
Luc J W van der Laan, Luc Magré, Monique M A Verstegen, Sonja Buschow, Maikel Peppelenbosch, Jyaysi Desai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 5 (2023)
In the past decade, treatments targeting the immune system have revolutionized the cancer treatment field. Therapies such as immune checkpoint inhibitors have been approved as first-line treatment in a variety of solid tumors such as melanoma and non
Externí odkaz:
https://doaj.org/article/e3abb4b4956942ebb00fa43fcb12ef3c
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/82eb10ccb7074478a04b322c3915515b
Autor:
Zhouhong Ge, Jean C.A. Helmijr, Maurice P.H.M. Jansen, Patrick P.C. Boor, Lisanne Noordam, Maikel Peppelenbosch, Jaap Kwekkeboom, Jaco Kraan, Dave Sprengers
Publikováno v:
Translational Oncology, Vol 14, Iss 7, Pp 101073- (2021)
Background and aims: Circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) may be used for diagnostic or prognostic purposes in patients with hepatocellular carcinoma (HCC). We aim to determine whether CTCs or ctDNA are suitable to determin
Externí odkaz:
https://doaj.org/article/591e1e52f33c46c38f40316de973d6aa
Autor:
Stefano Piatto Clerici, Maikel Peppelenbosch, Gwenny Fuhler, Sílvio Roberto Consonni, Carmen Veríssima Ferreira-Halder
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Colorectal cancer (CRC) is in the top 10 cancers most prevalent worldwide, affecting equally men and women. Current research on tumor-derived extracellular vesicles (EVs) suggests that these small extracellular vesicles (sEVs) play an important role
Externí odkaz:
https://doaj.org/article/06029083f0be4b9d937a8850dc091b97
Autor:
Marcel Rodrigues Ferreira, Renato Milani, Elidiane C. Rangel, Maikel Peppelenbosch, Willian Zambuzzi
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
For bone purposes, surface modifications are a common trend in biomaterials research aiming to reduce the time necessary for osteointegration, culminating in faster recovery of patients. In this scenario, analysis of intracellular signaling pathways
Externí odkaz:
https://doaj.org/article/7875a94f148c429e9e305e18f8b02037
Publikováno v:
Biomedicines, Vol 9, Iss 11, p 1680 (2021)
Gastric cancer (GC) is one of the global leading causes of cancer death. The association between Helicobacter pylori, which is a predominant risk factor for GC, with GC development has been well-studied. Recently, accumulating evidence has demonstrat
Externí odkaz:
https://doaj.org/article/5d0d18c0936d42a88e815c6778ecbbbf
Autor:
J Jasper Deuring, Meng Li, Wanlu Cao, Sunrui Chen, Wenshi Wang, Colin de Haar, C Janneke van der Woude, Maikel Peppelenbosch
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0221924 (2019)
BACKGROUND:The Pregnane X Receptor (PXR) is a principal signal transducer in mucosal responses to xenobiotic stress. It is well-recognized that inflammatory bowel disease is accompanied by xenobiotic stress, but the importance of the PXR in limiting
Externí odkaz:
https://doaj.org/article/caf190e9286d4a5ab759df7e3e8ae72a
Autor:
Daniel Pecher, Svetlana Dokupilová, Zuzana Zelinková, Maikel Peppelenbosch, Jana Lučeničová, Veronika Mikušová, Peter Mikuš
Publikováno v:
Molecules, Vol 23, Iss 7, p 1744 (2018)
Thiopurines (TP) represent an important therapeutic tool for the treatment of inflammatory bowel diseases (IBD) in the current situation of rising incidence and health care costs. The results of multiple clinical studies aimed at finding correlations
Externí odkaz:
https://doaj.org/article/a031652354bf4ff39d9d6089a7d4e30a
Autor:
Xumin Ou, Zhishuang Yang, Dekang Zhu, Sai Mao, Mingshu Wang, Renyong Jia, Shun Chen, Mafeng Liu, Qiao Yang, Ying Wu, Xinxin Zhao, Shaqiu Zhang, Juan Huang, Qun Gao, Yunya Liu, Ling Zhang, Maikel Peppelenbosch, Qiuwei Pan, Anchun Cheng
Publikováno v:
Transboundary and Emerging Diseases. 69